Tech Company Financing Transactions
Radius Health Funding Round
Radius Health closed a $91 million funding round on 5/24/2011. Investors included BB Biotech Ventures , Brookside Capital and GE Healthcare Financial Services.
Transaction Overview
Company Name
Announced On
5/24/2011
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$91,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Radius will use the proceeds primarily to fund Phase 3 clinical development of the subcutaneous injection form of BA058, the company's novel, proprietary PTHrP (parathyroid hormone-related protein) analog, for the treatment of osteoporosis.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
950 Winter St.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
Radius (NASDAQ: RDUS) is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jesper Høiland
Chief Financial Officer
Jose Carmona
Chief Medical Officer
Lorraine Fitzpatrick
Chief Scientific Officer
Gary Hattersley
Vice President
Amanda Mott
VP - General Counsel
Brent Hatzis-Schoch
VP - Human Resources
Deborah Kauffman
VP - Operations
Chhaya Shah
VP - Sales
Joseph Kelly
Browse more venture capital transactions:
Prev: 5/24/2011: CatchFree venture capital transaction
Next: 5/24/2011: ProteinSimple venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs